We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Show more
Achieved $6.2 million in ZURZUVAEโข (zuranolone) collaboration revenue during the first quarter of 2024, representing 50% of the net revenues reported by Biogen Encouraging initial demand for...
- In the Phase 2 PRECEDENT Study, dalzanemdor (SAGE-718) did not show statistically significant differences versus placebo on the primary endpoint in patients with mild cognitive impairment in...
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Thursday, April...
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -1.15356885364 | 13.87 | 14.71 | 12.84 | 1111001 | 13.59253439 | CS |
4 | -2.76 | -16.7577413479 | 16.47 | 17.045 | 10.92 | 1301772 | 14.05815848 | CS |
12 | -10.14 | -42.5157232704 | 23.85 | 27.39 | 10.92 | 1090591 | 18.42952505 | CS |
26 | -5.95 | -30.2644964395 | 19.66 | 28.26 | 10.92 | 977615 | 20.32146758 | CS |
52 | -32.88 | -70.5730843529 | 46.59 | 59.99 | 10.92 | 1105920 | 25.0899914 | CS |
156 | -65.58 | -82.7090427544 | 79.29 | 80.23 | 10.92 | 775159 | 34.30618295 | CS |
260 | -152.17 | -91.7349891488 | 165.88 | 193.56 | 10.92 | 756908 | 49.17072184 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions